Research and Clinical Trials
Search Cancer Clinical Trials
Clinical Trials
New Search
| Title | A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma |
|---|---|
| Disease/Condition | Soft Tissue Sarcoma/Cancer |
| Description | The purpose of this study is to evaluate whether overall survival for the trabectedin group is superior to the dacarbazine group for patients with advanced L-sarcoma (liposarcoma or leiomyosarcoma). |
| Eligibility Criteria | To be eligible for this study, patients must meet several criteria, including but not limited to the following: * Patient must be 15 Years and older * Subjects must have locally advanced or spreading liposarcoma (dedifferentiated, myxoid round cell, or pleomorphic) or leiomyosarcoma. |
| Principal Investigator | Petra Rietschel, MD |
| Contact Name | Janice Simpson, NP |
| Phone | (718) 920-4057 |
| Contact Email | jansimps@montefiore.org |
| Post Date | 04/26/2011 |
| Protocol Number | 11-06-234/West |
| Status | Recruiting |
| Current Trial Type | Interventional |
